Clarivate
A global information-services and analytics brand serving scientific research, intellectual property, academia, life sciences, and public-sector organizations.
Last updated November 4, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Clarivate is a British-American information-services and analytics company whose subscription products help organizations discover, evaluate, protect, and commercialize knowledge and intellectual property. Its customers include universities, research institutions, publishers, governments, pharmaceutical and biotechnology companies, healthcare organizations, patent departments, law firms, and brand owners. The company was formed in 2016 after Onex Corporation and Baring Private Equity Asia acquired Thomson Reuters’ Intellectual Property and Science business for approximately $3.55 billion. The transaction closed on October 4, 2016, creating an independent company initially known as Clarivate Analytics. The business inherited a large portfolio of bibliometric, patent, trademark, scientific, and research-management assets. These included the Web of Science family, Derwent patent-information services, CompuMark trademark research, and related intellectual-property products. Clarivate became publicly traded in 2019 through a merger with Churchill Capital Corp, a special-purpose acquisition company. Its shares began trading on the New York Stock Exchange under the symbol CLVT. The public company subsequently expanded through a series of acquisitions. Important additions included Publons, Kopernio, TrademarkVision, SequenceBase, Darts-ip, Decision Resources Group, CustomersFirst Now, CPA Global, and ProQuest. The ProQuest acquisition, completed in 2021, materially broadened Clarivate’s academic and government portfolio by adding scholarly content, library systems, research workflows, and other information products. Clarivate’s principal activities are organized around three broad areas: Intellectual Property; Life Sciences and Healthcare; and Academia and Government. Web of Science supports citation indexing, research discovery, bibliometrics, and evaluation. Associated offerings include Journal Citation Reports, Essential Science Indicators, InCites, EndNote, Publons, and research-workflow tools. The company also publishes the annual Highly Cited Researchers list and produces analyses such as the Top 100 Global Innovators report. In intellectual property, Derwent products provide patent searching, classification, analytics, sequence information, and prosecution support. CompuMark services help trademark professionals screen proposed marks, conduct clearance research, and monitor possible infringement. Other acquired capabilities have addressed IP administration, case-law analytics, and patent-practice workflows. In life sciences and healthcare, Cortellis and related products provide intelligence on drug discovery, clinical trials, regulatory affairs, competitive activity, deals, digital health, generics, and manufacturing controls. Clarivate has also managed a portfolio of acquired software and data brands, which has produced both breadth and integration challenges. Some businesses have been divested, including Techstreet, MarkMonitor, Valipat, and ScholarOne. ScholarOne was sold to Silverchair in 2024, while MarkMonitor was sold to Newfold Digital in 2022. The company operates in a concentrated market for academic and professional information. Critics have argued that consolidation, price increases for some acquired products, limited integration or development of certain offerings, outsourcing, and reductions in telephone support have affected customers and employees. These criticisms are part of the wider debate over the cost, governance, and competitive structure of scholarly databases. Clarivate has continued to position itself as a provider of trusted data, analytics, workflow software, and decision support across research and professional knowledge markets.
History
Clarivate originated in the intellectual-property and science-information operations of Thomson Reuters. On July 11, 2016, Thomson Reuters agreed to sell that business to Onex Corporation and Baring Private Equity Asia for approximately $3.55 billion. The transaction closed on October 4, 2016, and the acquired operations became an independent company known as Clarivate Analytics. Its inherited portfolio included Web of Science, scientific and research analytics, patent databases, trademark information, and intellectual-property workflow services. The new company pursued a strategy of assembling specialized information businesses around high-value professional workflows. In 2017 it acquired Publons, a platform that records and recognizes scholarly peer review. In 2018 it acquired Kopernio, which helped researchers locate accessible full-text articles, and TrademarkVision, an artificial-intelligence company focused on trademark image searching. In 2019 Clarivate added SequenceBase for biological and chemical patent-sequence information and Darts-ip for intellectual-property case-law data and analytics. Clarivate entered the public markets in 2019 through a merger with Churchill Capital Corp. The transaction provided a New York Stock Exchange listing under CLVT. The company continued its acquisition-led expansion in 2020, purchasing Decision Resources Group for healthcare and life-sciences intelligence, CustomersFirst Now for IP software and services, and CPA Global for intellectual-property administration technology and related services. The 2021 acquisition of ProQuest was one of Clarivate’s most consequential expansions. It added scholarly publishing content, library technology, research-management resources, and products inherited by ProQuest through earlier acquisitions, including Innovative Interfaces offerings. The deal strengthened Clarivate’s academic and government segment and increased the breadth of its subscription and workflow portfolio. Clarivate has periodically reshaped the portfolio through divestitures. Techstreet was sold in 2020, MarkMonitor was sold to Newfold Digital in 2022, and Valipat was divested in 2024. In November 2024, ScholarOne was sold to Silverchair. These transactions reflected a continuing effort to focus the company on selected research, analytics, intellectual-property, and life-sciences activities. By 2023, Clarivate described its operations through three strategic business units: Intellectual Property; Life Sciences and Healthcare; and Academia and Government. Its major product families included Web of Science and related research analytics, Cortellis life-sciences intelligence, Derwent patent services, CompuMark trademark services, and ProQuest’s academic and library products. Leadership changed significantly in 2022. Jerre Stead moved from executive chair and CEO toward a non-executive chair role, while Jonathan Gear became CEO on September 1. Stead subsequently retired from the board and became chair emeritus. In 2024 Clarivate appointed Matti Shem Tov, formerly associated with ProQuest, as chief executive officer. The company has attracted criticism concerning the economics and governance of scholarly information. Observers and customers have raised concerns about market concentration, increases in prices for some acquired products, insufficient integration or development of acquired services, outsourcing of work from the United States and United Kingdom to India, and the removal of telephone support for some products. These issues sit within a broader debate about the market power of large academic-database providers, rather than representing a single confirmed corporate scandal. Clarivate remains an active global provider of subscription data, analytics, content, and workflow software.
- 2024
Matti Shem Tov becomes CEO
[1]Clarivate appointed Matti Shem Tov, formerly associated with ProQuest, as chief executive officer.
- 2023
Chief executive transition
[8]Jonathan Gear succeeded Jerre Stead as chief executive officer.
- 2022
Russia commercial activity discontinued
[1]Clarivate announced that it would cease commercial activity in Russia after the full-scale invasion of Ukraine.
- 2021
ProQuest acquisition completed
[1]Clarivate acquired ProQuest, expanding its academic, library, research, and government information businesses, including the Ex Libris Alma and Primo platforms. Clarivate completed its acquisition of ProQuest, adding substantial scholarly-content, library, dissertation, and research-workflow capabilities.
- 2020
Expansion into healthcare and IP administration
[1]Clarivate acquired Decision Resources Group, CustomersFirst Now, and CPA Global.
- 2020
Public listing on the New York Stock Exchange
[8]The Churchill Capital Corp III transaction closed and Clarivate began trading on the NYSE under the symbol CLVT.
- 2019
Public listing on the NYSE
[1]Clarivate merged with Churchill Capital Corp and began trading as CLVT. It also added SequenceBase for biological and chemical patent-sequence information and Darts-ip for intellectual-property case-law data and analytics.
- 2019
Agreement to combine with Churchill Capital Corp III
[8]Clarivate announced a transaction intended to convert the private company into a publicly traded business through a merger with Churchill Capital Corp III.
- 2018
Kopernio and TrademarkVision acquisitions
[1]Clarivate acquired Kopernio, which helped researchers locate accessible full-text articles, and TrademarkVision, an artificial-intelligence company focused on trademark image searching.
- 2017
Publons acquisition
[1]Clarivate acquired Publons, a platform for documenting and recognizing scholarly peer review.
Products and positioning
Premium, subscription-based information, workflow software, and analytics for research, intellectual property, life sciences, healthcare, and professional decision-making. Clarivate positions itself as a provider of trusted data, analytics, and workflow software for research, intellectual property, life sciences, and academic institutions, combining curated content, proprietary databases, citation and patent intelligence, and tools that support decisions across the research and innovation lifecycle.
Research database and analytics
Web of Science
Web of Science is Clarivate’s citation-indexing and research-discovery platform. It supports literature searching, citation analysis, bibliometric evaluation, and the construction of research-performance indicators. Its data underpins associated services such as Journal Citation Reports and Essential Science Indicators and is used by researchers, universities, funders, publishers, and governments. Web of Science is Clarivate's flagship research-discovery and citation-indexing platform. It provides structured access to scholarly literature and citation relationships across selected journals, conference proceedings, books, and other research sources. Universities, publishers, funders, government agencies, and corporations use it for literature discovery, citation analysis, collaboration studies, research evaluation, and strategic planning. Its value depends on curated coverage, normalized metadata, historical citation links, and tools that allow users to examine research influence across disciplines.
Life sciences intelligence
Cortellis
Cortellis is a family of intelligence products for pharmaceutical, biotechnology, medical-device, and healthcare organizations. Its coverage includes clinical trials, competitive intelligence, licensing and deals, drug discovery, regulatory affairs, digital health, generics, and chemistry, manufacturing, and controls. The products are designed to support decisions across the development and commercialization lifecycle. Cortellis is Clarivate's family of life-sciences intelligence products. It covers areas such as drug pipelines, clinical trials, regulatory developments, companies, deals, patents, and commercial information. Pharmaceutical and biotechnology organizations use Cortellis to monitor competitors, evaluate assets, track development programs, support licensing and business-development work, and inform research and commercial strategy.
Patent information and analytics
Derwent
Derwent provides patent searching, classification, analytics, and intellectual-property workflow capabilities. The portfolio includes Derwent Innovation, Derwent Data Analyzer, Derwent SequenceBase, and GENESEQ. It is used by patent professionals, research teams, corporate IP departments, and legal advisers to investigate inventions, portfolios, technologies, and competitive activity. Derwent provides patent searching, classification, analytics, and intellectual-property workflow capabilities. The portfolio includes Derwent Innovation, Derwent Data Analyzer, Derwent SequenceBase, GENESEQ, and the Derwent World Patents Index, a structured patent-information resource designed to improve the discovery and comparison of inventions across jurisdictions through standardized titles, abstracts, and classifications. It is used by patent professionals, research teams, corporate IP departments, technology-transfer offices, and legal advisers to investigate inventions, portfolios, technologies, and competitive activity.
Trademark research and protection
CompuMark
CompuMark supplies trademark-searching, screening, clearance, and monitoring services. Products and services associated with the portfolio include SAEGIS, TM go365, analyst-led full searches, and trademark watching. The offering helps brand owners and trademark professionals assess proposed marks and identify potentially conflicting or infringing uses.
Academic and library information services · 2021
ProQuest
ProQuest operates within Clarivate's academic and government portfolio and provides scholarly content, research resources, library technologies, and related workflow products, including dissertations, theses, newspapers, archival material, ebooks, databases, and discovery services. The portfolio also includes products brought into ProQuest through earlier acquisitions, including library-management systems and platforms associated with Innovative Interfaces. ProQuest provides academic and research content, including dissertations, theses, newspapers, archival material, ebooks, databases, and discovery services. Within Clarivate, the ProQuest portfolio extends access to research materials and supports library acquisition, discovery, digitization, and institutional research workflows.
Research workflow software
EndNote
EndNote is a reference-management and research-writing product associated with Clarivate. It helps users collect, organize, cite, and format scholarly references and bibliographies. It is part of Clarivate’s broader research-workflow ecosystem alongside Web of Science and related discovery services. EndNote is reference-management software used to collect, organize, annotate, and cite scholarly sources. It supports research workflows by helping users build bibliographies, manage reference libraries, and format citations for different publication styles. The product has long been associated with individual researchers, graduate students, academic departments, and institutions.
Scholarly publishing workflow
ScholarOne
ScholarOne is a manuscript-submission and peer-review management system for academic journals. It supports electronic submission, reviewer recruitment, editorial workflows, compliance checks, and communication with authors. Clarivate sold the business to Silverchair in 2024.
Journal analytics
Journal Citation Reports
Journal Citation Reports provides journal-level indicators and descriptive information derived from citation data. It is used by researchers, librarians, publishers, and research managers to compare journals, understand citation patterns, and support collection and publication decisions. The product is associated with the Journal Impact Factor and a wider set of journal metrics, although Clarivate presents the indicators as analytical tools that require contextual interpretation rather than as a single universal measure of quality.
Research-performance analytics
Essential Science Indicators
Essential Science Indicators supports analysis of research performance, citation influence, emerging areas, highly cited papers, and institutional or national output. It is used by research administrators, policymakers, funders, and strategy teams to benchmark performance across fields and identify influential work. The service complements Web of Science by presenting citation-based indicators in a more analytical and comparative format.
Patent information
Derwent World Patents Index
Derwent World Patents Index is a structured patent-information resource designed to improve the discovery and comparison of inventions across jurisdictions. Derwent editorial processes enrich patent records with standardized titles, abstracts, classifications, and related information. Patent professionals, corporate research teams, technology-transfer offices, and law firms use the data for prior-art research, competitive intelligence, portfolio review, freedom-to-operate analysis, and technology landscaping.
Library-management system
Ex Libris Alma
Alma is a cloud-based library-management platform associated with Clarivate's Ex Libris business. It helps academic and research libraries manage print, electronic, and digital resources, acquisitions, cataloging, fulfillment, and related operational workflows. Its role is to provide a shared management environment for complex library collections and services.
Marketing campaigns
- 2020Top 100 Global Innovators report
Global
Clarivate's annual report identifies organizations with strong patent performance, valuable inventions, commercialization potential, and influence on subsequent innovation.
Outcome. The report established a recurring public-facing innovation ranking and analysis.
- 2019Highly Cited Researchers list
Global
Clarivate publishes an annual list identifying researchers whose papers rank among the top one percent by citations for their field and publication year in Web of Science data. The list is used as a visibility and recognition program for influential research and has become a prominent research-recognition and communications initiative associated with the Web of Science and Clarivate research-intelligence portfolio. Clarivate publishes the annual Highly Cited Researchers recognition program using citation data and field-specific methodology to identify researchers whose publications have demonstrated substantial influence.
Outcome. The annual program became a recurring Clarivate research-impact publication. The program has become a prominent research-recognition and communications initiative associated with the Web of Science and Clarivate research-intelligence portfolio.
Brand decisions
2024
Appointment of Matti Shem Tov as CEOOtherBackground
Clarivate undertook a further leadership transition after Jonathan Gear's tenure as CEO.
Action taken
Clarivate appointed former ProQuest chief executive Matti Shem Tov as chief executive officer.
Aftermath
The appointment connected Clarivate's corporate leadership with the ProQuest business acquired in 2021.
2022
Withdrawal from commercial activity in RussiaStrategyBackground
Clarivate had an office in Odesa, Ukraine, and responded to Russia's full-scale invasion of Ukraine.
Action taken
The company announced that it would cease all commercial activity in Russia.
Aftermath
Clarivate removed its commercial operations from the Russian market while continuing to operate internationally.
2021
Acquisition of ProQuestM&ABackground
Clarivate pursued broader coverage of academic, library, research, and government information markets.
Action taken
Clarivate acquired ProQuest and integrated its products into the Academia and Government portfolio.
Aftermath
The transaction significantly expanded Clarivate's scholarly content, library technology, and research-workflow capabilities.
2021
Acquire ProQuestM&ABackground
Clarivate aimed to expand beyond bibliographic and citation products into academic content, library services, and research workflows.
Action taken
Clarivate completed the acquisition of ProQuest and its related academic and library businesses.
Aftermath
The acquisition broadened Clarivate's portfolio through ProQuest content, Ex Libris library platforms, and additional institutional research capabilities.
2019
Public-market merger with Churchill Capital CorpM&ABackground
Clarivate sought a public listing after operating as an independently owned information-services company since 2016.
Action taken
Clarivate merged with Churchill Capital Corp and listed on the New York Stock Exchange under CLVT.
Aftermath
The transaction made Clarivate a publicly traded company and provided the platform for subsequent acquisition and portfolio strategies.
2019
Pursue a public listing through Churchill Capital Corp IIIM&ABackground
Clarivate sought access to public capital markets while remaining focused on information and analytics businesses.
Action taken
The company agreed to combine with Churchill Capital Corp III, a special-purpose acquisition company.
Aftermath
The transaction closed in 2020 and Clarivate became listed on the New York Stock Exchange under CLVT.
2016
Separate the Thomson Reuters Intellectual Property & Science divisionM&ABackground
Thomson Reuters decided to sell its Intellectual Property & Science operations as part of a broader portfolio strategy.
Action taken
Onex and Baring Private Equity Asia acquired the division for approximately $3.55 billion and established it as Clarivate Analytics.
Aftermath
The transaction created an independent specialist information-services company centered on research, patent, and life-sciences intelligence.
Recent events
Reported
STMicroelectronics named to 2022 Top 100 Global Innovators[10]
Clarivate named STMicroelectronics among its 2022 Top 100 Global Innovators.
Reported
TE Connectivity named a Clarivate Top 100 Global Innovator[11]
Clarivate recognized TE Connectivity as one of its Top 100 Global Innovators 2022 for the 11th straight year.
Epson named a Clarivate Top 100 Global Innovator[12]
Seiko Epson Corporation was listed among the Clarivate Top 100 Global Innovators 2022; the article says this was the ninth time Epson had been named to the list.
Reported
Clarivate acquires Patient Connect[13]
Clarivate announced that it had acquired Patient Connect, a provider of patient-engagement solutions.
Reported
Clarivate completes acquisition of ProQuest[14]
Clarivate completed its acquisition of ProQuest after satisfying customary closing conditions. The transaction was announced on May 17, 2021.
Reported
Clarivate acquires Bioinfogate[15]
Clarivate announced that it had acquired Bioinfogate, a provider of life sciences analytics solutions and producer of the OFF-X portal. The acquisition will add Bioinfogate's drug toxicity data and translational safety intelligence to Clarivate's offerings.
- Unconfirmed
National labs and publishing organizations establish a name-change process[16]
All 17 U.S. national laboratories, including SLAC, partnered with scientific publishers and other organizations on a process to help researchers request name changes on previously published papers.
Reported
Clarivate launches Cortellis Supply Chain Network[17]
Clarivate announced the launch of Cortellis Supply Chain Network, a solution in its Cortellis life science intelligence suite that connects buyers and sellers and provides supply-chain data and tools.
Reported
Clarivate prices ordinary and convertible preferred share offerings[18]
Clarivate announced pricing for concurrent offerings of ordinary shares and 5.25% Series A mandatory convertible preferred shares. The offerings were expected to close on June 14, 2021, subject to customary closing conditions.
Reported
Clarivate partners with Explore IP[19]
Clarivate announced an exclusive commercial partnership with Explore IP to integrate Derwent patent data into Explore IP's platform. The announcement described the data as intended to help organizations discover and assess intellectual property held by public-sector institutions.
Sources29 sources
- 1Clarivateen.wikipedia.org
- 2Clarivate investor relationsir.clarivate.com
- 3Clarivate newsroomclarivate.com
- 4Clarivate corporate websiteclarivate.com
- 5Clarivate management informationir.clarivate.com
- 6Clarivate Highly Cited Researchersclarivate.com
- 7Clarivate newsroomclarivate.com
- 8Agreement to combine with Churchill Capital Corp IIIir.clarivate.com
- 9Appointment of Matti Shem Tov as CEOclarivate.com
- 10意法半导体入选2022年全球百大创新机构chinatimes.com
- 11TE Connectivity获评Clarivate全球百强创新机构prnewswire.com
- 12Epson入选Clarivate全球百大创新机构whattheythink.com
- 13Clarivate收购Patient Connectprnewswire.com
- 14Clarivate完成对ProQuest的收购prnewswire.com
- 15Clarivate收购Bioinfogateprnewswire.com
- 16美国国家实验室与出版机构建立姓名变更流程miragenews.com
- 17Clarivate推出Cortellis供应链网络prnewswire.com
- 18Clarivate 为普通股及可转换优先股发行定价prnewswire.com
- 19Clarivate与Explore IP建立合作prnewswire.com
- 20Clarivate收购Hanlim IPSprnewswire.com
- 21Clarivate公布2021年调整后每股收益展望prnewswire.com
- 22Clarivate 完成对 CPA Global 的收购prnewswire.co.uk
- 23Clarivate同意收购Decision Resources Groupequitybulls.com
- 24Piramal将DRG出售给Clarivatebusiness-standard.com
- 25Piramal Enterprises同意将DRG出售给Clarivate Analyticsfinancialexpress.com
- 26Clarivate扩大并确定高级担保票据发行规模及价格benzinga.com
- 27Clarivate Analytics Plc Announces Upsizing and Pricing of Offering of Ordinary Sharesprnewswire.com
- 28Clarivate Announces Pricing of Offering of $1.0 Billion Senior Secured Notes and $1.0 Billion Senior Notesprnewswire.com
- 29Piramal Divests its DRG Business for US$950 Millionequitybulls.com
Cite this profile: Cite the canonical profile. /brand-wiki/clarivate · Editorial policy · How profiles are compiled